Research and experimental development on natural sciences and engineering
IMMUNOQUEST THERAPEUTICS AS
Revenue 2024
NOK 0
Operating profit
NOK −718,000
Equity
NOK −721,000
Incorporated
2023
Share capital
NOK 43,000
Roles
Regnskapsfører
Styrets lederHåvard Selby Ebbestad
StyremedlemMorten Hugo Egeberg
StyremedlemAnders Pablo Kapstad
StyremedlemKari Grønås
StyremedlemVidar Gordon Flote
VaramedlemKnut Erik Skullerud
Auditor
Auditor at related companies
None of the 1 related companies use the same auditor.
| Company | Auditor | |
|---|---|---|
| INVEN2 AS | PRICEWATERHOUSECOOPERS AS | different |
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| INVEN2 AS | 60.0% | 18000.000000 | 2025 |
| JON AMUND KYTE | 20.0% | 6000.000000 | 2025 |
| THE N AS | 20.0% | 6000.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.